Praluent (Alirocumab)

Praluent is a member of a new class of lipid-lowering agents known as PCSK9 inhibitors. It is self-administered as a subcutaneous injection in a single-use pre-filled pen or pre-filled syringe. It is indicated for use as an adjunct to diet and maximally tolerated...